Ad is loading...
BUFEX
Price
$54.72
Change
-$1.09 (-1.95%)
Updated
Nov 15 closing price
GFACX
Price
$69.11
Change
-$1.16 (-1.65%)
Updated
Nov 15 closing price
Ad is loading...

BUFEX vs GFACX

Header iconBUFEX vs GFACX Comparison
Open Charts BUFEX vs GFACXBanner chart's image
Buffalo Blue Chip Growth
Price$54.72
Change-$1.09 (-1.95%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$69.11
Change-$1.16 (-1.65%)
VolumeN/A
CapitalizationN/A
BUFEX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BUFEX vs. GFACX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BUFEX is a StrongBuy and GFACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 298B vs. BUFEX (151M). BUFEX pays higher dividends than GFACX: BUFEX (0.03) vs GFACX (0.00). BUFEX was incepted earlier than GFACX: BUFEX (30 years) vs GFACX (24 years). BUFEX is a more actively managed with annual turnover of: 46.00 vs. GFACX (31.00). GFACX has a lower initial minimum investment than BUFEX: GFACX (250) vs BUFEX (2500). BUFEX annual gain was more profitable for investors over the last year : 32.12 vs. GFACX (25.86). BUFEX return over 5 years is better than : 60.30 vs. GFACX (44.67).
BUFEXGFACXBUFEX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years24 years-
Gain YTD26.14125.655102%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets151M298B0%
Annual Yield % from dividends0.030.00-
Returns for 1 year32.1225.86124%
Returns for 3 years-3.80-8.3945%
Returns for 5 years60.3044.67135%
Returns for 10 years116.4154.23215%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UFI5.60-0.05
-0.88%
UNIFI
FIVE87.02-1.03
-1.17%
Five Below
EXK4.70-0.06
-1.26%
Endeavour Silver Corp
TCRT2.09-0.25
-10.59%
Alaunos Therapeutics Inc.
ARWR18.57-2.84
-13.26%
Arrowhead Pharmaceuticals